Newsroom

Stay informed

All

Stories

Events

23 Articles

Sep 2025Zydus and Synthon entered into exclusive licensing and supply agreement for Ozanimod Capsules for the U.S. market

Jun 2025Synthon Announces Investment from Goldman Sachs Alternatives

Jan 2023Silver Medal in EcoVadis Assessment 2024Stories

15 April, 2024Leaders in Life Sciences Podcast Events

Synthon CEO Anish Mehta shares his career journey, leadership insights, and strategic vision for the future of generic medicines in an engaging conversation with Henk Jan Out on the Leaders in Life Sciences Podcast.

Click here to tune in to gain valuable perspectives on innovation, market challenges, and Synthon’s role in advancing the pharmaceutical industry.

Jan 2024Zydus and Synthon enter into an exclusive licensing and supply agreement for Palbociclib Tablets for the US marketStories

Zydus Lifesciences Ltd., a global innovation driven healthcare company announced that its wholly owned subsidiary, Zydus Worldwide DMCC, has entered into an exclusive licensing and supply agreement with Synthon BV for Palbociclib Tablets (a generic version of IBRANCE®) for the US market.

Dec 2023Synthon celebrates second year of support for Amalia's Kinderziekenhuis Stories

Synthon proudly announces its continued support for Amalia's Kinderziekenhuis for the second consecutive year. Our company is happy to reveal a total of €12,164 raised during the recent fundraising campaign.

Nov 2023CPHI 2023 was a great successThank you for another successful CPHI. For the past three days, our committed team met with customers, suppliers and potential new partners from the international pharmaceutical industry. Thank you all for these successful days. We can't wait to see you again next year!Stories

Jun 2023Synthon announces successful bioequivalence studies for Bempedoic acidSynthon is proud to announce the completion of two successful bioequivalence (BE) studies for Bempedoic acid, a product we are developing for our valued partners.Stories

Jan 2023Extension Synthon HispaniaSynthon keeps growing. With our extension of Synthon Hispania, we will enhance our R&D capacity and expand our production capacity.Stories

Dec 2022Synthon donates to Amalia Children's HospitalWe are very pleased to announce that Synthon B.V. is supporting Amalia children’s fund by donating a financial gift and materials for the children in the hospital. All employees from Synthon Nijmegen contributed to the donation.Stories

Dec 2022Synthon and SAJA sign agreement to commercialize a basket of productsSynthon is pleased to announce that it has entered into a partnership with Saudi-based SAJA, to commercialize several products in the MENA region.Stories

Jul 2022Support Team WikkeOur colleague Liselijn Wisman is raising funds during de Nijmeegse Vierdaagse for the Oogfonds. Her son Wikke has the rare Leber's disease.Stories